We are 3-methyl-7H-xanthine CAS:1076-22-8 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests
Chemical Name: 3-methyl-7H-xanthine
CAS.NO: 1076-22-8
Synonyms:
3-METHYL XANTHINE
3-Methylxanthine
3-METHYL-2,3,6,9-TETRAHYDRO-1H-PURINE-2,6-DIONE
3,7-dihydro-3-methyl-1h-purine-6-dione
1H-PURINE-2,6-DIONE,3,9-DIHYDRO-3-METHYL-
3-methyl-7H-purine-2,6-dione
2,6-Dihydroxy-3-methylpurine
3,7-DIHYDRO-3-METHYL-1H-PURINE-2,6-DIONE
3-Methyl-1H-purine-2,6(3H,7H)-dione
Molecular Formula: C6H6N4O2
Molecular Weight: 166.13700
Physical and Chemical Properties:
Density: 1.539 g / cm3
Boiling point: 322.4ºC at 760 mmHg
Melting point:> 300 ° C (lit.)
Flash point: 148.8ºC
Refractive index: 1.827
Specification:
Appearance: Light yellow to yellow solid
Purity:≥97.0%
Moisture:≤2.0%
Loss on drying:≤2.0%
Packing:
25kg cardboard drum or according to customer specified requirements
Storage:Storage conditions: 2-8ºC.Keep container tightly closed in a cool, dry place.
Application:3-methylxanthine is a metabolite of theophylline. It is a xanthine derivative with diuretic, cardiotonic and relaxing smooth muscle functions. It is an isomer of theobromine. Can also be used as abronchodilator.Intermediates of Linagliptin CAS:668270-12-0.
Related News: An analysis of the top 20 global companies by R&D spend for 2018 shows that companies with expensive late-stage pipeline drugs are spending significant proportions of their annual revenue on R&D.4-chloro-1-benzothiophene CAS:66490-33-3 Drug manufacturers make medicines by mixing APIs and pharmaceutical excipients.4,5-bis (2-metoxietoxi) -2-nitrobenzonitrilo CAS:236750-65-5 Drug manufacturers make medicines by mixing APIs and pharmaceutical excipients.chlorodimethylvinylsilane CAS:1719-58-0 The company’s iPSC product platform unites stem cell biology and precision genetic engineering to create renewable master engineered iPSC lines that can be repeatedly used to mass produce cancer-fighting immune cells, replacing the high production costs, weeks of manufacturing time, and complex engineering processes required for current-generation CAR T-cell immunotherapies with an off-the-shelf product that has the potential to reach many more patients.The company’s iPSC product platform unites stem cell biology and precision genetic engineering to create renewable master engineered iPSC lines that can be repeatedly used to mass produce cancer-fighting immune cells, replacing the high production costs, weeks of manufacturing time, and complex engineering processes required for current-generation CAR T-cell immunotherapies with an off-the-shelf product that has the potential to reach many more patients.
Product Name | |
---|---|
L-1-Cbz-Nipecotic Acid Cas:88466-74-4 | View Details |
(S)-3-(Boc-amino)pyrrolidine Cas:122536-76-9 | View Details |
2-Bromo-6-nitrotoluene | View Details |